Mots-clés
 > MYOBASE > SANTE > médecine > maladie > pathologie > degré de sévérité
degré de sévéritéSynonyme(s)severe form ;forme grave ;serious form ;bénin ;mild form ;forme atténuée ;benign form ;disease gravity ;disease severity ;gravité de la maladie ;forme bénigne forme sévère |
Documents disponibles dans cette catégorie (614)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
A 22-year follow-up reveals a variable disease severity in early-onset facioscapulohumeral dystrophy
Goselink RJM, van Kernebeek CR, Mul K, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2018
Retrospective natural history of thymidine kinase 2 deficiency
Garone C, Taylor RW, Nascimento A, et al.
Journal of medical genetics, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
Glascock J, Sampson J, Haidet-Phillips A, et al.
Journal of Neuromuscular Diseases, 2018
Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients
Catapano F, Domingos J, Perry M, et al.
Epigenomics, 2018
Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry
Lee I, Kaminski HJ, Xin H, et al.
Muscle & Nerve, 2018
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis
Yeker RM, Pinal-Fernández I, Kishi T, et al.
Annals of the rheumatic diseases, 2018
The role of electrodiagnosis with long exercise test in McArdle disease
Semplicini C, Hézode-Arzel M, Laforêt P, et al.
Muscle & Nerve, 2018
Fatigue is a relevant outcome in patients with myasthenia gravis
Tran C, Bril V, Katzberg HD, et al.
Muscle & Nerve, 2018
Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis
Yan C, Song J, Pang S, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2018, 48, p 238
Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes Is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy
Savino W, Pinto-Mariz F, Mouly V
Methods in molecular biology, 2018, 1687, p 219
Neurofilament light, biomarkers, and Charcot-Marie-Tooth disease
Pareyson D, Shy ME
Neurology, 2018, 90, 6, p 257
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
Sandelius Å, Zetterberg H, Blennow K, et al.
Neurology, 2018, 90, 6, p 518
Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy
De Santis R, Pane M, Coratti G, et al.
Neuromuscular disorders : NMD, 2018, 28, 1, p 24
Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy
De Sanctis R, Pane M, Coratti G, et al.
Neuromuscular disorders : NMD, 2018, 28, 1, p 24
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis
Schmidt S, Hafner P, Klein A, et al.
Neuromuscular disorders : NMD, 2018, 28, 1, p 16
Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion
Pogoryelova O, Cammish P, Mansbach H, et al.
Neuromuscular disorders : NMD, 2018, 28, 2, p 158
Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
Calucho M, Bernal S, Alias L, et al.
Neuromuscular disorders : NMD, 2018, 28, 3, p 208
Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation
Alavi A, Esmaeili S, Nafissi S, et al.
Neuromuscular disorders : NMD, 2018, 28, 4, p 303
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis
Aouizerate J, De Antonio M, Bader-Meunier B, et al.
Rheumatology (Oxford, England), 2018, 57, 5, p 873
Cognitive impairment, clinical severity and MRI changes in MELAS syndrome
Kraya T, Neumann L, Paelecke-Habermann Y, et al.
Mitochondrion, 2017
Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1
Hogrel JY, Ollivier G, Ledoux I, et al.
Annals of clinical and translational neurology, 2017, 4, 12, p 921
Multiple antibody detection in 'seronegative' myasthenia gravis patients.
Hong Y, Zisimopoulou P, Trakas N, et al.
European journal of neurology, 2017, 24, 6, p 844
Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
Moreira S, Wood L, Smith D, et al.
Journal of neurology, 2017, 264, 6, p 1271
